Related Experiment Video
Updated: Jun 3, 2025

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
Published on: August 11, 2008
Contribution of Video Directly Observed Therapy (VDOT) to Tuberculosis Treatment in Brazil
Luana Michelly Aparecida Costa Dos Santos1,2, Alan Maicon de Oliveira3,4,5, Guilherme José Aguilar2,6
1Department of Public Health, Ribeirão Preto Medical School, University of São Paulo (USP), Ribeirão Preto, São Paulo, Brazil.
Abstract:
Directly Observed Treatment (DOT) involves the administration of medication and in-person monitoring by a healthcare team alongside the patient to improve adherence to tuberculosis (TB) treatment. Implementing DOT requires healthcare professionals, transportation, time dedication, and presence at the patient's residence. Meeting all these conditions is not always possible to address the high demand of TB patients who would benefit from this supervision. Video Directly Observed Therapy (VDOT) is a telecare platform created to remotely oversee the treatment of TB patients, allowing them to daily record medication intake, as prescribed, using their cell phones, clarify doubts, and facilitate communication with the healthcare team providing support. The medication intake data is recorded and accessible to healthcare professionals who monitor adherence remotely. The investigation reported in this work was conducted in Ribeirão Preto, Brazil, from May 5, 2020, to May 4, 2023, across five healthcare units. During the study period, 26,253 medication intake videos were collected and sent from 259 patients. Regarding the outcome reported by supervisors, only 9.7% of patients had their VDOT follow-up terminated due to abandonment, while the Cure/Treatment completion rate was 57.5%. Regarding adherence to the established treatment period for TB and for each patient in their specific situation, 67% of patients completed more than 66% of the treatment. The data suggested good acceptance of the system by both patients and healthcare professionals. VDOT may be a promising tool that complements TB DOT, extending its reach to improve adherence and reduce abandonment rates.
More Related Videos
06:26Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
Published on: July 28, 2023
09:34An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
Published on: August 16, 2021
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...